PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy

Published:2015-06 Issue:3 Volume:88 Page:254-259
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chang Yih-Leong,Yang Ching-Yao,Lin Mong-Wei,Wu Chen-Tu,Yang Pan-Chyr

Funder

National Taiwan University Hospital, Taipei, Taiwan

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. PD-L1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008

2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000

3. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

4. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

5. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical treatment strategy and follow-up of lymphoepithelioma-like carcinoma: a retrospective study;Future Science OA;2024-08-30

2. Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases;Diagnostic Pathology;2024-01-04

3. Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study;Radiotherapy and Oncology;2023-12

4. Neoadjuvant immunochemotherapy—a novel strategy for primary pulmonary lymphoepithelioma-like carcinoma;2023-09-22

5. Targeted therapy for rare lung cancers: Status, challenges, and prospects;Molecular Therapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3